Skip to main navigation Skip to search Skip to main content

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: A children's oncology group phase I consortium study

  • Yael P. Mossé
  • , Emily Lipsitz
  • , Elizabeth Fox
  • , David T. Teachey
  • , John M. Maris
  • , Brenda Weigel
  • , Peter C. Adamson
  • , Mark A. Ingle
  • , Charlotte H. Ahern
  • , Susan M. Blaney

Research output: Contribution to journal › Article › peer-review

116   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: A children's oncology group phase I consortium study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science